Moderna announced Thursday it will receive up to $54.3 million from a global vaccine partnership to fund its ongoing research ...
Moderna will get up to $54.3 million in funding from a global coalition to support late-stage development of its experimental bird flu vaccine, the U.S. drugmaker said on Thursday.
The Coalition for Epidemic Preparedness Innovations said it will invest $54.3 million with Moderna to fund a Phase 3 trial of its bird flu vaccine.